CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

In a multivariate analysis of 154 patients receiving chemotherapy, baseline CA19-9 was an independent prognostic factor for overall survival (OS) (HR 1.8; 95% CI: 1.3–2.5, P=0.0004). The 1-year OS was 19 and 46%, respectively, for patients with a baseline CA19-9 above or below the median value. A fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Maisey, N R, Norman, A R, Hill, A, Massey, A, Oates, J, Cunningham, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361637/
https://www.ncbi.nlm.nih.gov/pubmed/16175188
http://dx.doi.org/10.1038/sj.bjc.6602760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361637/
https://www.ncbi.nlm.nih.gov/pubmed/16175188
http://dx.doi.org/10.1038/sj.bjc.6602760

Ejemplares similares